TRANSFARMATIVE Trademark

Trademark Overview


On Friday, December 15, 2023, a trademark application was filed for TRANSFARMATIVE with the United States Patent and Trademark Office. The USPTO has given the TRANSFARMATIVE trademark a serial number of 98317233. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, July 17, 2024. This trademark is owned by ULTRA YIELD SOLUTIONS, LLC. The TRANSFARMATIVE trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Horticulture consulting services for commercial indoor farming
transfarmative

General Information


Serial Number98317233
Word MarkTRANSFARMATIVE
Filing DateFriday, December 15, 2023
Status641 - NON-FINAL ACTION - MAILED
Status DateWednesday, July 17, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesHorticulture consulting services for commercial indoor farming

Classification Information


International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, December 15, 2023
Primary Code044
First Use Anywhere DateThursday, September 14, 2023
First Use In Commerce DateThursday, September 14, 2023

Trademark Owner History


Party NameULTRA YIELD SOLUTIONS, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressRye, NY 10580

Trademark Events


Event DateEvent Description
Friday, December 15, 2023NEW APPLICATION ENTERED
Friday, March 29, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 16, 2024ASSIGNED TO EXAMINER
Wednesday, July 17, 2024NON-FINAL ACTION E-MAILED
Wednesday, July 17, 2024NON-FINAL ACTION WRITTEN
Wednesday, July 17, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED